Published • loading... • Updated
Trump announces all 50 states joining Medicaid drug pricing model
The White House says the plan could save state governments $27.6 billion and the federal government $36.6 billion over 10 years.
- On Friday, President Donald Trump announced the expansion of the "Most Favored Nation" drug pricing model to all 50 states, the District of Columbia, and Puerto Rico, aligning U.S. prescription costs with international rates.
- Dubbed the Medicaid "GENEROUS" model, the initiative relies on agreements with global manufacturers including Pfizer, Eli Lilly, and Novo Nordisk to secure lower prices comparable to other developed nations.
- The White House Council of Economic Advisers projects the effort could save $529 billion over 10 years, including $27.6 billion in net savings for state governments and $36.6 billion in federal savings.
- Kathy Hempstead, a senior policy advisor at the Robert Wood Johnson Foundation, warned that the lack of public deal details creates a barrier to legislative action and pressures the administration to release granular data.
Insights by Ground AI
30 Articles
30 Articles
White House announces all Medicaid programs get Trump-negotiated drug prices
President Donald Trump is expected to announce new, lower prescription drug prices for Medicaid programs across the country. Trump will announce on Friday that Medicaid programs in all 50 states, Washington D.C., and Puerto Rico will now benefit from lower prices negotiated by the administration with pharmaceutical companies as part of the president’s “most favored […]
·Washington, United States
Read Full Article
Coverage Details
Total News Sources30
Leaning Left8Leaning Right4Center15Last UpdatedBias Distribution55% Center
Bias Distribution
- 55% of the sources are Center
55% Center
L 30%
C 55%
15%
Factuality
To view factuality data please Upgrade to Premium
